Table 4.
Echocardiogram | RAS inhibitors | Beta‐blockers | MRAs | |||||
---|---|---|---|---|---|---|---|---|
Non‐adherent | Adherent | Non‐adherent | Adherent | Non‐adherent | Adherent | Non‐adherent | Adherent | |
Hospitalizations | ||||||||
Heart failure | 332 | 417 | 300 | 304 | 306 | 309 | 334 | 316 |
Other cardiovascular diseases | 462 | 549 | 376 | 362 | 358 | 358 | 356 | 336 |
All other causes | 1852 | 1849 | 1911 | 1611 | 1811 | 1704 | 2012 | 1698 |
Medications | ||||||||
RAS inhibitors or beta‐blockers or MRAs | 136 | 165 | 123 | 167 | 126 | 173 | 142 | 166 |
All other drugs | 1548 | 1773 | 1440 | 1505 | 1528 | 1591 | 1883 | 1815 |
Outpatient services | ||||||||
Echocardiogram | 10 | 43 | 14 | 14 | 13 | 15 | 14 | 15 |
Other outpatient services | 1085 | 1140 | 708 | 646 | 834 | 732 | 689 | 514 |
Total | 5425 | 5936 | 4872 | 4610 | 4975 | 4883 | 5430 | 4859 |
MRAs, mineralocorticoid receptor antagonists; RAS, renin–angiotensin system.